2 results match your criteria: "Salzburg University Hospital (SALK)[Affiliation]"
Iron depletion with a novel apheresis system in patients with hemochromatosis.
Transfusion
May 2015
Blood Group Serology and Transfusion Medicine, Salzburg University Hospital (SALK), Salzburg, Austria.
Background: Phlebotomy represents the standard treatment option for iron overload in hemochromatosis (HC). Recently, red blood cell (RBC) apheresis has increasingly been used to remove iron. In this study we evaluated the depletion program of the newly developed Spectra Optia device.
View Article and Find Full Text PDFT-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy.
Vox Sang
January 2015
Blood Group Serology and Transfusion Medicine, Salzburg University Hospital (SALK), Salzburg, Austria; Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Background And Objectives: Extracorporeal photochemotherapy (ECP) is an established therapy in various diseases, such as cutaneous T-cell lymphoma and graft-versus-host disease. This study was performed to investigate the practicability of a flow cytometric T-cell evaluation after ECP as a tool to validate the quality of ECP procedures and to enable the comparability of treatments with different ECP devices.
Materials And Methods: Peripheral blood mononuclear cells (PBMNCs) of healthy volunteer blood donors were treated by offline ECP.